Subscribe to our RSS feed

Popular News Stories

  • Fuck poz guys!
  • Tom Hanks in Philadelphia Changed my Life
  • Canadian AIDS Society’s AGM and PHA Forum in Ottawa: some scholarships for HIVers available
  • Semen goes viral – or does it?
  • BareBackRT.com  - the interview

Hep B and C

Nov29

Co-infection news - new treatments for hepatitis C

Saturday, 29 November 2014 Written by // Guest Authors - Revolving Door Categories // Hep B and C, Research, Health, Treatment, Living with HIV, Revolving Door, Guest Authors

aidsmap.com reports there’s more good news on treatment for hepatitis C. In several trials of new hepatitis C drugs involving people with hepatitis C and HIV co-infection, over 90% of HIV-positive people had no traces of hepatitis C after 12 weeks

Co-infection news  - new treatments for hepatitis C

This article previously appeared in HIVupdate, a publication of aidsmap.com 

There’s more good news on treatment for hepatitis C. In several trials of new hepatitis C drugs involving people with hepatitis C and HIV co-infection, over 90% of HIV-positive people had no traces of hepatitis C after 12 weeks of treatment. The drug regimens are made up of tablets only, often with more than one drug combined into a single tablet, and no injections of interferon are needed.

Until recently, it was thought that recommendations for treating people who have HIV and hepatitis C co-infection had to be different from those for people with hepatitis C mono-infection. This was because people with HIV co-infection tended to have a poorer response to hepatitis C treatment and separate clinical trials were needed.

But we now know that when a potent combination of two or three new hepatitis C drugs is taken, people with HIV co-infection can have results that are comparable to people who only have hepatitis C.

In the following studies, people were generally already doing well on HIV treatment, with undetectable viral loads and good CD4 counts. But most had hepatitis C genotype 1a, which until now has been considered ‘hard to treat’. And most had an inherited gene which meant that they would probably not do well on hepatitis treatment that includes interferon injections.

The first study tested two new drugs, sofosbuvir and ledipasvir, which are combined in a single tablet called Harvoni. The tablet was approved by European regulators last week. Researchers gave the treatment to 50 HIV-positive people, none of whom had taken hepatitis C treatment before. Most had a high hepatitis C viral load and a quarter had advanced liver fibrosis (but none had cirrhosis, the more serious scarring of the liver). After 12 weeks of treatment, all but one of the patients were cured of hepatitis C.

A rival drug company is offering a regimen which includes three new drugs. This regimen involves a tablet called Viekirax (which combines two new drugs, ombitasvir and paritaprevir, as well as a ritonavir booster), another new drug dasabuvir (Exviera), and the option to take these alongside the existing drug ribavirin. European regulators have given preliminary support to this combination, with a final decision expected next year.

To test this regimen, another small study recruited HIV-positive people who were mostly taking hepatitis treatment for the first time. One in five had liver cirrhosis. Whether people took the drugs for 12 or 24 weeks, over 90% had no traces of hepatitis C after the treatment was finished. A larger trial will confirm which length of treatment is best.

And another study tested the so-far unlicensed combination of two new drugs, grazoprevir and elbasvir. Treatment for people living with HIV was most successful when the combination was taken along with ribavirin – in 97% of people, hepatitis C could not be detected.

In all these studies, side-effects were not a major problem.

Finally, a study showed good outcomes for people living with HIV who had liver transplants. The transplants were all done because the person had hepatocellular carcinoma (HCC, a type of liver cancer that may occur when a person has cirrhosis). People who had a transplant did better than people who had their liver cancer treated in another way. Outcomes after a transplant were as good for people living with HIV as for people who didn’t have HIV. HIV UPdate, a publication of aidsmap.com 

Arts and Entertainment Section

  • Skimming pebbles: Part two

    Skimming pebbles: Part two

    In part two of Dave R’s story, Andy struggles with what he’s learned and tries to balance deep dilemmas with his own reality. In the end, the choice is taken out of his hands but should he have done more? Would you have done more?
  • Season’s greetings

    Season’s greetings

    Bob Leahy and his dogs on doing what doesn’t come naturally, pet photography and Christmas spent away from home
  • Skimming pebbles: Part one

    Skimming pebbles: Part one

    Fiction from Dave R - a two-part story set in the South Seas. A man tries to escape his past by moving to what he hopes may be paradise. However, the serpent there confronts him with dilemmas he desperately hoped to avoid.

Activism Section

Current Affairs Section

Events Section

  • Living with HIV in Canada?

    Living with HIV in Canada?

    The federal funding agency PHAC wants to hear your views on how they propose distributing funds to the agencies that serve us, and how those services will be delivered
  • Honoured for their work

    Honoured for their work

    PositiveLite.com was at the 2014 Ontario AIDS Network Honour Roll Awards in Toronto last week to celebrate the induction of the four 2014 award winners.
  • Gains and…challenges

    Gains and…challenges

    COCQ-SIDA's new campaign takes on HIV stigma by matching the gains in the fight against HIV/AIDS against the challenges that remain. Ken Monteith reports.

Features and Interviews Section

Health Section

International Section

Legal Section

Lifestyle Section

  • Chemsex: it’s toxic . . .

    Chemsex: it’s toxic . . .

    True life story from FS Magazine about crystal meth “The stories I had heard, which I thought were myths, were very, very true”
  • How to have a threesome

    How to have a threesome

    Lots of couples decide to have threesomes to spice up their sex life together. It can be the beginning of a new stage in their sexual relationship or the end of the whole relationship. FS Magzine finds out how to know if three’s company or a crowd.
  • Season’s greetings

    Season’s greetings

    Bob Leahy and his dogs on doing what doesn’t come naturally, pet photography and Christmas spent away from home

Living with HIV Section

Media Section

Opinion Pieces Section

Population Specific Section

Sex and Sexuality Section

MarketPlace